Report overview
This report contains market size and forecasts of Liposomal Drug Delivery Device in Global, including the following market information:
Global Liposomal Drug Delivery Device Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Liposomal Drug Delivery Device market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Stealth Liposome Technology Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Liposomal Drug Delivery Device include Novartis AG, Luye Pharma Group, Ipsen Pharma, Celsion, Inc., Galen Limited, Astellas Pharma, Inc., Acrotech Biopharma, Inc., Fudan-Zhangjiang and Pacira, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Liposomal Drug Delivery Device companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomal Drug Delivery Device Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Liposomal Drug Delivery Device Market Segment Percentages, by Type, 2022 (%)
Stealth Liposome Technology
NonPEGylated Liposome Technology
DepoFoam Liposome Technology
Global Liposomal Drug Delivery Device Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Liposomal Drug Delivery Device Market Segment Percentages, by Application, 2022 (%)
Fungal Diseases
Cancer Therapy
Pain Management
Viral Vaccines
Photodynamic Therapy
Global Liposomal Drug Delivery Device Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Liposomal Drug Delivery Device Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomal Drug Delivery Device revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Liposomal Drug Delivery Device revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Luye Pharma Group
Ipsen Pharma
Celsion, Inc.
Galen Limited
Astellas Pharma, Inc.
Acrotech Biopharma, Inc.
Fudan-Zhangjiang
Pacira
Creative Biolabs
Precision NanoSystems Inc.
Encapsula NanoSciences LLC
Avanti Polar Lipids, Inc.
Viatris Inc.
Merrimack Pharmaceuticals, Inc
